teclistamab
Treatment with teclistamab, a T-cell–redirecting bispecific antibody, led to a “high rate of deep and durable...
Among 37 evaluable patients, the ORR was 78%, and 27 patients had a VGPR or better...
Advertisement
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.